Amundi Pioneer Asset Management Inc. Purchases 352,420 Shares of Colgate-Palmolive (NYSE:CL)


Share on StockTwits

Amundi Pioneer Asset Management Inc. lifted its position in Colgate-Palmolive (NYSE:CL) by 12.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,238,097 shares of the company’s stock after acquiring an additional 352,420 shares during the quarter. Amundi Pioneer Asset Management Inc. owned 0.38% of Colgate-Palmolive worth $276,887,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Wolff Wiese Magana LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter worth about $25,000. Advisory Alpha LLC purchased a new position in Colgate-Palmolive in the 3rd quarter worth about $28,000. Grant Street Asset Management Inc. purchased a new position in Colgate-Palmolive in the 4th quarter worth about $28,000. Accel Wealth Management purchased a new position in Colgate-Palmolive in the 4th quarter worth about $33,000. Finally, Kinloch Capital LLC purchased a new position in Colgate-Palmolive in the 4th quarter worth about $34,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Several research analysts recently commented on CL shares. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $83.00 price target on the stock. in a research note on Thursday, January 28th. Sanford C. Bernstein initiated coverage on shares of Colgate-Palmolive in a research note on Tuesday, January 19th. They issued an “underperform” rating and a $77.00 price target on the stock. Credit Suisse Group raised shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and raised their target price for the company from $70.00 to $80.00 in a research report on Monday, February 1st. Royal Bank of Canada downgraded shares of Colgate-Palmolive from an “outperform” rating to a “sector perform” rating and set a $90.00 target price on the stock. in a research report on Monday, January 4th. Finally, Berenberg Bank raised shares of Colgate-Palmolive from a “sell” rating to a “hold” rating and set a $76.00 target price on the stock in a research report on Tuesday, January 26th. Two analysts have rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $81.91.

In other Colgate-Palmolive news, VP Philip G. Shotts sold 346 shares of the business’s stock in a transaction that occurred on Tuesday, February 16th. The shares were sold at an average price of $77.16, for a total transaction of $26,697.36. Following the sale, the vice president now owns 41,128 shares of the company’s stock, valued at approximately $3,173,436.48. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Jennifer Daniels sold 20,692 shares of the business’s stock in a transaction that occurred on Thursday, February 4th. The stock was sold at an average price of $78.65, for a total transaction of $1,627,425.80. Following the sale, the insider now directly owns 55,585 shares in the company, valued at approximately $4,371,760.25. The disclosure for this sale can be found here. In the last quarter, insiders have sold 30,810 shares of company stock valued at $2,418,650. 0.78% of the stock is currently owned by company insiders.

NYSE CL opened at $79.62 on Thursday. The company has a quick ratio of 0.62, a current ratio of 0.97 and a debt-to-equity ratio of 6.50. The firm has a market cap of $67.48 billion, a PE ratio of 25.44, a price-to-earnings-growth ratio of 3.83 and a beta of 0.59. The company has a 50 day moving average price of $76.89 and a 200 day moving average price of $80.38. Colgate-Palmolive has a 52 week low of $65.54 and a 52 week high of $86.41.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Thursday, January 28th. The company reported $0.77 EPS for the quarter, topping the consensus estimate of $0.76 by $0.01. The firm had revenue of $4.32 billion during the quarter, compared to analyst estimates of $4.15 billion. Colgate-Palmolive had a net margin of 16.65% and a return on equity of 383.88%. Colgate-Palmolive’s revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.73 EPS. On average, equities research analysts anticipate that Colgate-Palmolive will post 3.05 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 14th. Investors of record on Wednesday, April 21st will be paid a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 2.26%. The ex-dividend date is Tuesday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.44. Colgate-Palmolive’s payout ratio is 62.19%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment's products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.

Recommended Story: Do back-end load funds outperform no-load funds?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.